CN Patent

CN104784166A — 抗病毒化合物、包含该化合物的剂型及其用途

Assigned to Biocryst Pharmaceuticals Inc · Expires 2015-07-22 · 11y expired

What this patent protects

本发明为抗病毒化合物、包含该化合物的剂型及其用途。本发明涉及式Ia化合物或其药学上可接受的盐在制备用于治疗人类对象的流感感染的药物中的用途，以及包含Ia化合物或其药学上可接受的盐的静脉内单位剂型

USPTO Abstract

本发明为抗病毒化合物、包含该化合物的剂型及其用途。本发明涉及式Ia化合物或其药学上可接受的盐在制备用于治疗人类对象的流感感染的药物中的用途，以及包含Ia化合物或其药学上可接受的盐的静脉内单位剂型

Drugs covered by this patent

Patent Metadata

Patent number: CN104784166A
Jurisdiction: CN
Classification: —
Expires: 2015-07-22
Drug substance claim: No
Drug product claim: No
Assignee: Biocryst Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.